27 Apr 2018

Clinical Outcomes: a small data-set


Clinical outcomes.


Thank you, David.  The part I like best is "In all 7 the resolution continues".   The part I am sorry about is so little faith, so little compliance.  Personally, I have other things I would rather do, but the trade-off is  -  let me see, should I make a list beginning with thinking, dressing, swallowing, walking..........17 months, every day  and my list continues to grow.


Ignorance is voluntary bad luck.  Lauritz S.   A true Viking

If you come to a fork in the road, take it. Yogi Berra

3/9 Symptoms returning. Began 5 abx protocol 5/9 Rifampin 600, Amox 1000, Doxy 200, MWF Azith 250, flagyl 1000 daily. Began Sept 04 PPMS EDSS 6.7 Now good days EDSS 1 Mind, like parachute, work only when open. Charlie Chan  In for the duration.&am

 David- Thanks for posting this. Really important to have actual data sets available. So many of us "in process" here that it's hard to stand back and know how powerful this work is. These results are unheard of for MS. Guess this isn't just a pet theory, huh? This goes in the Handbook!

On Wheldon/Stratton protocol for Cpn in CFS/FMS since December 2004.

Here is a very interesting and very positive 9-month-long trial for spondyloarthropathy in which chlamydial involvement was suspected. Doxy alone did very little. The patients in the "real" treatment arm, doxy plus rifampin, saw ~2x reductions in multiple measures - pain (visual analog scale), morning stiffness (hours), tender joint count, swollen joint count.

J Rheumatol 31.10.1973-80, 2004.

I think there are also some negative trials out there for a similar patient population. One would want to examine whether the regimes used in such trials might simply have been far too weak.

More great news - thank-you so much for the report!




On Wheldon protocol for MS since April, 2006.  LDN 1994

5oo mgs Ceftin 2 x/day, 500 mgs Zithromax, 500 mgs 2 x tini pulses,100 mg diflucan, 4.5 ldn; Wheldon protocol for MS April, 2006 to May 2008. 2008 MRI shows NO NEW DISEASE ACTIVITY, 2012 MRI no new disease activity.